N

Novoray Corp
SSE:688300

Watchlist Manager
Novoray Corp
SSE:688300
Watchlist
Price: 90.05 CNY -5.59% Market Closed
Market Cap: ¥21.7B

Novoray Corp
Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Novoray Corp
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
N
Novoray Corp
SSE:688300
Operating Expenses
-¥123.7m
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
G
Grace Fabric Technology Co Ltd
SSE:603256
Operating Expenses
-¥156.7m
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Hengli Petrochemical Co Ltd
SSE:600346
Operating Expenses
-¥3.6B
CAGR 3-Years
12%
CAGR 5-Years
-16%
CAGR 10-Years
-17%
Satellite Chemical Co Ltd
SZSE:002648
Operating Expenses
-¥2.3B
CAGR 3-Years
-8%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
G
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
Operating Expenses
-¥1.8B
CAGR 3-Years
-1%
CAGR 5-Years
-26%
CAGR 10-Years
-25%
Rongsheng Petrochemical Co Ltd
SZSE:002493
Operating Expenses
-¥4.2B
CAGR 3-Years
8%
CAGR 5-Years
-12%
CAGR 10-Years
-17%
No Stocks Found

Novoray Corp
Glance View

Market Cap
21.7B CNY
Industry
Chemicals

In the bustling landscape of modern technology companies, Novoray Corp has carved out a niche with its cutting-edge solutions in the realm of imaging and radiography technology. Founded by a group of visionary engineers and entrepreneurs, Novoray emerged from the need to innovate within medical and industrial sectors. The company has honed its expertise in developing advanced imaging systems that harness the power of digital radiography and computed tomography. These systems find applications in diverse fields ranging from healthcare diagnostics to industrial non-destructive testing, offering unparalleled clarity and precision. Novoray's commitment to research and development is evident in its consistently innovative product lineup, attracting a loyal clientele composed of hospitals, manufacturing units, and research institutions worldwide. At the heart of Novoray's business model lies its multi-faceted revenue streams. The company generates income by selling state-of-the-art imaging equipment, complemented by service contracts for maintenance and upgrades, ensuring clients have continuous access to the latest technology. Beyond hardware sales, Novoray has strategically boosted its recurring revenue through software solutions that enhance image processing and diagnostics. This software-as-a-service (SaaS) approach facilitates smooth integration into clients' existing systems, driving efficiency and improving outcomes. Additionally, Novoray capitalizes on training and consultancy services, empowering clients to leverage their technology to its full potential. Through these various avenues, Novoray Corp not only sustains its financial health but also secures a reputation as a leader in precision imaging solutions.

Intrinsic Value
44.77 CNY
Overvaluation 50%
Intrinsic Value
Price ¥90.05
N

See Also

What is Novoray Corp's Operating Expenses?
Operating Expenses
-123.7m CNY

Based on the financial report for Dec 31, 2024, Novoray Corp's Operating Expenses amounts to -123.7m CNY.

What is Novoray Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-14%

Over the last year, the Operating Expenses growth was -23%. The average annual Operating Expenses growth rates for Novoray Corp have been -15% over the past three years , -15% over the past five years , and -14% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett